Brief: Vaccitech Reports Q1 2022 Results
11/05/2022 22:04
May 11 (Reuters) - Vaccitech PLC VACC.O :
* VACCITECH REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND
RECENT CORPORATE DEVELOPMENTS
* Q1 EARNINGS PER SHARE $0.07
Source text for Eikon: ID:nGNX8J95tm
Further company coverage: VACC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Barinthus Biotherapeutics
See all newsBrief: Barinthus Bio Provides Update On Proposed Combination With Clywedog Therapeutics
Brief: Barinthus Biotherapeutics PLC Appoints Douglas Swirsky As CFO And Principal Accounting Officer Effective May 1, 2026
Brief: Barinthus Bio Announces Update On Phase 1 AVALON Clinical Trial Of VTP-1000 For The Treatment Of Celiac Disease
Brief: Barinthus Bio Reports Second Quarter 2025 Financial Results And Updates On Corporate Developments
Gemma Brown Terminated As CFO Effective April 30, 2025 - SEC Filing